The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in moderately emetogenic therapy (MEC).
 
Paul Joseph Hesketh
Research Funding - ArQule (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst)
 
Lee Steven Schwartzberg
Leadership - Vector Oncology
Consulting or Advisory Role - Amgen; Eisai; Genentech; Teva
Speakers' Bureau - Eisai; Genentech; Novartis
Research Funding - Eisai
 
Manuel R. Modiano
Stock and Other Ownership Interests - Pharmacyclics; Reliant Heart; Syncardia
Research Funding - Arizona Clinical Research Center (I)
 
Sujata Arora
Stock and Other Ownership Interests - Medtronic; Tesaro
Consulting or Advisory Role - Tesaro
Travel, Accommodations, Expenses - Tesaro
 
Allen Poma
Employment - Tesaro
Stock and Other Ownership Interests - Tesaro
 
Ian D. Schnadig
Employment - Compass Oncology; McKesson
Travel, Accommodations, Expenses - Tesaro